Home

omdømme last Hvert år ecco guidelines biologics støvle Il Panorama

European Crohn´s and Colitis Organisation - ECCO - Published ECCO Guidelines
European Crohn´s and Colitis Organisation - ECCO - Published ECCO Guidelines

Mistakes in opportunistic infections and vaccinations in IBD and how to  avoid them | UEG - United European Gastroenterology
Mistakes in opportunistic infections and vaccinations in IBD and how to avoid them | UEG - United European Gastroenterology

COVID-19 and IBD: Guidance from IOIBD and ECCO on management of patients |  International Organization For the Study of Inflammatory Bowel Disease
COVID-19 and IBD: Guidance from IOIBD and ECCO on management of patients | International Organization For the Study of Inflammatory Bowel Disease

Biologic agents for IBD: practical insights | Nature Reviews  Gastroenterology & Hepatology
Biologic agents for IBD: practical insights | Nature Reviews Gastroenterology & Hepatology

British Society of Gastroenterology consensus guidelines on the management  of inflammatory bowel disease in adults | Gut
British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults | Gut

Evidence-based clinical practice guidelines for inflammatory bowel disease  2020 | SpringerLink
Evidence-based clinical practice guidelines for inflammatory bowel disease 2020 | SpringerLink

European Crohn´s and Colitis Organisation - ECCO - Published ECCO Guidelines
European Crohn´s and Colitis Organisation - ECCO - Published ECCO Guidelines

De-escalation of immunomodulator and biological therapy in inflammatory  bowel disease - The Lancet Gastroenterology & Hepatology
De-escalation of immunomodulator and biological therapy in inflammatory bowel disease - The Lancet Gastroenterology & Hepatology

European Crohn´s and Colitis Organisation - ECCO - Published ECCO Guidelines
European Crohn´s and Colitis Organisation - ECCO - Published ECCO Guidelines

PDF) ECCO Guidelines on the Prevention, Diagnosis, and Management of  Infections in Inflammatory Bowel Disease
PDF) ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease

Adaptations to the current ECCO/ESPGHAN guidelines on the management of  paediatric acute severe colitis in the context of the COVID-19 pandemic: a  RAND appropriateness panel | Gut
Adaptations to the current ECCO/ESPGHAN guidelines on the management of paediatric acute severe colitis in the context of the COVID-19 pandemic: a RAND appropriateness panel | Gut

JCM | Free Full-Text | An Update on Current Pharmacotherapeutic Options for  the Treatment of Ulcerative Colitis
JCM | Free Full-Text | An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis

Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric  Crohn's disease - ScienceDirect
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease - ScienceDirect

Frontiers | Oral Delivery of Biologics in Inflammatory Bowel Disease  Treatment
Frontiers | Oral Delivery of Biologics in Inflammatory Bowel Disease Treatment

First-line therapy in adult Crohn's disease: who should receive anti-TNF  agents? | Nature Reviews Gastroenterology & Hepatology
First-line therapy in adult Crohn's disease: who should receive anti-TNF agents? | Nature Reviews Gastroenterology & Hepatology

Use of biologics and small molecule drugs for the management of moderate to  severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE  methodology - Digestive and Liver Disease
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology - Digestive and Liver Disease

Preparing Patients With Inflammatory Bowel Diseases For Biological  Therapies In Clinical Practice | Chebli | Journal of Gastroenterology and  Hepatology Research
Preparing Patients With Inflammatory Bowel Diseases For Biological Therapies In Clinical Practice | Chebli | Journal of Gastroenterology and Hepatology Research

ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment

European Crohn´s and Colitis Organisation - ECCO - P429 Continued  postoperative use of biologics for the prevention of recurrence of Crohn's  disease
European Crohn´s and Colitis Organisation - ECCO - P429 Continued postoperative use of biologics for the prevention of recurrence of Crohn's disease

British Society of Gastroenterology consensus guidelines on the management  of inflammatory bowel disease in adults | Gut
British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults | Gut

ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections  in Inflammatory Bowel Disease
ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease

Accepted Manuscript
Accepted Manuscript

JCM | Free Full-Text | The Optimal Management of Fistulizing Crohn’s  Disease: Evidence beyond Randomized Clinical Trials
JCM | Free Full-Text | The Optimal Management of Fistulizing Crohn’s Disease: Evidence beyond Randomized Clinical Trials

Evidence-based clinical practice guidelines for inflammatory bowel disease  2020 | SpringerLink
Evidence-based clinical practice guidelines for inflammatory bowel disease 2020 | SpringerLink

Changing the Game in Ulcerative Colitis: The Impact of Gut-Selective  Therapy - European Medical Journal
Changing the Game in Ulcerative Colitis: The Impact of Gut-Selective Therapy - European Medical Journal

2022 ECCO Guidelines on the Treatment of Ulcerative Colitis - EMJ
2022 ECCO Guidelines on the Treatment of Ulcerative Colitis - EMJ

Cureus | Use of Azathioprine in Ulcerative Colitis: A Comprehensive Review  | Article
Cureus | Use of Azathioprine in Ulcerative Colitis: A Comprehensive Review | Article

Newer Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease  | NEJM
Newer Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease | NEJM